Founded in 2014 and headquartered in the Hi-tech Medical Device Park of Wuhan Optics Valley Biolake, bms is a high-tech enterprise dedicated to innovation in the blood medical technology industry. bms adheres to the principle of "Leading by Innovation Excellence by Quality" consistently advancing the pioneering research, development, production, and application of cutting-edge blood medical technologies.
bms Core Technologies
bms's product portfolio spans four key domains: Blood Transfusion Medicine (BCT), Cell and Gene Therapy (CGT), Biopharmaceuticals (BIO) and Autologous Serum Therapy (ASE) . The company's operations encompass the R&D and manufacturing of medical devices and consumables related to biotechnology and life sciences. Key products include Sterile Tube Welders, Versatile Tube Sealer, and Automatic Blood Separator, Blood Collection and ASE medical disposables. Developed entirely through in-house R&D, the proprietary technologies are protected by a comprehensive intellectual property portfolio. This achieves the leap from conceptual innovation to commercial industrialization.
bms Certificates
bms has achieved comprehensive breakthroughs in industry certifications, encompassing internationally recognized standards and domestic regulatory approvals in quality management, product safety, and market access, including ISO 13485 / ISO 9001 QMS, MDR Class I, U.S. FDA Approval, and 4 Medical Device Registration Certificates issued by China's National Medical Products Administration (NMPA).
bms Patents
bms holds over 65 patents, including more than 16 invention patents, which account for 25% of the total. All patents are independently developed, underscoring bms’commitment to proprietary innovation. Moreover, core technologies have been filed for patent protection in the US, Germany, and France, Germany, and France. bms ranks as the third company globally with proprietary intellectual property that integrates R&D, manufacturing, and marketing capabilities.
bms Rewards
As a national high-tech enterprise, bms has received numerous prestigious awards and recognitions at the national level. These honors, primarily conferred by key ministries including the Ministry of Science and Technology and the NMPA, underscore the company's leading position in technological innovation and the medical device sector. bms was first designated as a "National High-Tech Enterprise" in 2018 and has maintained this status consecutively. From 2022 to 2024, bms was consistently recognized as a "Hubei Provincial Gazelle Enterprise" for three consecutive years. In 2024, bms further achieved several distinctions, including registration of its National Patent-Intensive Products, a nomination for the Hubei Provincial Science and Technology Progress Award, and the provincially acclaimed "Specialized, Refined, Distinctive, and Innovative" SME title.
|
|
